Goldman Sachs’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-913,245
| Closed | -$68.7M | – | 5918 |
|
|
2022
Q2 | $68.7M | Buy |
913,245
+68,784
| +8% | +$5.18M | 0.02% | 786 |
|
|
2022
Q1 | $22.7M | Buy |
844,461
+43,252
| +5% | +$1.16M | ﹤0.01% | 1637 |
|
|
2021
Q4 | $38.2M | Buy |
801,209
+80,946
| +11% | +$3.86M | 0.01% | 1310 |
|
|
2021
Q3 | $47.8M | Sell |
720,263
-5,841
| -0.8% | -$388K | 0.01% | 1124 |
|
|
2021
Q2 | $56.7M | Buy |
726,104
+315,322
| +77% | +$24.6M | 0.01% | 979 |
|
|
2021
Q1 | $38.9M | Sell |
410,782
-117,427
| -22% | -$11.1M | 0.01% | 1198 |
|
|
2020
Q4 | $64.4M | Buy |
528,209
+86,936
| +20% | +$10.6M | 0.02% | 787 |
|
|
2020
Q3 | $38.6M | Buy |
441,273
+35,418
| +9% | +$3.09M | 0.01% | 1025 |
|
|
2020
Q2 | $26.2M | Buy |
405,855
+210,821
| +108% | +$13.6M | 0.01% | 1287 |
|
|
2020
Q1 | $8.71M | Buy |
195,034
+80,244
| +70% | +$3.58M | ﹤0.01% | 1883 |
|
|
2019
Q4 | $7.15M | Buy |
114,790
+82,553
| +256% | +$5.14M | ﹤0.01% | 2219 |
|
|
2019
Q3 | $1.21M | Buy |
32,237
+26,412
| +453% | +$993K | ﹤0.01% | 3144 |
|
|
2019
Q2 | $237K | Buy |
+5,825
| New | +$237K | ﹤0.01% | 3802 |
|